GWPH - GW Pharmaceuticals plc's (GWPH) CEO Justin Gover on Q3 2020 Results - Earnings Call Transcript
GW Pharmaceuticals plc (GWPH) Q3 2020 Results Earnings Conference Call November 3, 2020, 8:30 AM ET Company Participants Stephen Schultz - Vice President, Investor Relations Justin Gover - Chief Executive Officer Darren Cline - U.S. Chief Commercial Officer Chris Tovey - Chief Operating Officer Dr. Volker Knappertz - Chief Medical Officer Scott Giacobello - Chief Financial Officer Conference Call Participants Tazeen Ahmad - Bank of America Salveen Richter - Goldman Sachs Phil Nadeau - Cowen and Company Josh Schimmer - Evercore ISI Charles Duncan - Cantor Fitzgerald Marc Goodman - SVB Leerink Paul Matteis - Stifel Serge Belanger - Needham & Company Neena Bitritto-Garg - Citi David Lebowitz - Morgan Stanley Yatin Suneja - Guggenheim Partners David Kideckel - ATB Capital Markets Daniel Brill - Raymond James Francois Brisebois - Oppenheimer Douglas Tsao - H.C. Wainwright Presentation Operator Greetings. And welcome to the GW Pharmaceuticals Third Quarter 2020 Financial Results
For further details see:
GW Pharmaceuticals plc's (GWPH) CEO Justin Gover on Q3 2020 Results - Earnings Call Transcript